TY - JOUR
T1 - Summary of Keynote Speeches from the 2024 Voice AI Symposium, presented by the Bridge2AI-Voice Consortium
AU - the Bridge2AI-Voice Consortium
AU - Patel, Rupal
AU - Price, Nicholson
AU - Bahr, Ruth
AU - Bedrick, Steven
AU - Bensoussan, Yael
AU - Bélisle-Pipon, Jean Christophe
AU - Dorr, David
AU - Jackson, Christie
AU - Krussel, Andrea
AU - Salvi Cruz, Samantha
AU - Toghranegar, Jamie
AU - Watts, Stephanie
AU - Zhao, Robin
AU - Powell, Maria
N1 - Publisher Copyright:
2024 Patel, Price, Bahr, Bedrick, Bensoussan, Bélisle-Pipon, Dorr, Jackson, Krussel, Salvi Cruz, Toghranegar, Watts, Zhao, The Bridge2AI-Voice Consortium and Powell.
PY - 2024
Y1 - 2024
N2 - Introduction: The 2024 Voice AI Symposium, hosted by the Bridge2AI-Voice Consortium in Tampa, FL, featured two keynote speeches that addressed the intersection of voice AI, healthcare, ethics, and law. Dr. Rupal Patel and Dr. Nicholson Price provided insights into the advancements, applications, and challenges of AI-driven voice tools in healthcare. The symposium aimed to advance cross-disciplinary collaboration and establish frameworks for the ethical use of AI technologies in healthcare. Methods: The keynote speeches, delivered on May 1st and 2nd, were 30 minutes each, followed by 10-minutes Q&A sessions. The audio was recorded and transcribed using Whisper (v7.13.1). Content summaries were generated with the aid of ChatGPT (v4.0), and the authors reviewed and edited the final transcripts to ensure accuracy and clarity. Results: Dr. Rupal Patel’s keynote, “Reflections and New Frontiers in Voice AI”, explored the potential of voice AI for early detection of health conditions, monitoring disease progression, and promoting non-invasive global health management. She highlighted innovative uses beyond traditional applications, such as examining menopause-related symptoms. Dr. Nicholson Price’s keynote, “Governance for Clinical Voice AI”, addressed the regulatory and ethical challenges posed by AI in healthcare. He stressed the need for context-aware systems and dynamic legal frameworks to address liability and accountability. Conclusions: The 2024 Voice AI Symposium highlighted the transformative potential of voice AI for early detection, health monitoring, and reducing healthcare disparities. It also underscored the importance of dynamic governance to address the ethical and regulatory challenges of deploying AI in clinical settings.
AB - Introduction: The 2024 Voice AI Symposium, hosted by the Bridge2AI-Voice Consortium in Tampa, FL, featured two keynote speeches that addressed the intersection of voice AI, healthcare, ethics, and law. Dr. Rupal Patel and Dr. Nicholson Price provided insights into the advancements, applications, and challenges of AI-driven voice tools in healthcare. The symposium aimed to advance cross-disciplinary collaboration and establish frameworks for the ethical use of AI technologies in healthcare. Methods: The keynote speeches, delivered on May 1st and 2nd, were 30 minutes each, followed by 10-minutes Q&A sessions. The audio was recorded and transcribed using Whisper (v7.13.1). Content summaries were generated with the aid of ChatGPT (v4.0), and the authors reviewed and edited the final transcripts to ensure accuracy and clarity. Results: Dr. Rupal Patel’s keynote, “Reflections and New Frontiers in Voice AI”, explored the potential of voice AI for early detection of health conditions, monitoring disease progression, and promoting non-invasive global health management. She highlighted innovative uses beyond traditional applications, such as examining menopause-related symptoms. Dr. Nicholson Price’s keynote, “Governance for Clinical Voice AI”, addressed the regulatory and ethical challenges posed by AI in healthcare. He stressed the need for context-aware systems and dynamic legal frameworks to address liability and accountability. Conclusions: The 2024 Voice AI Symposium highlighted the transformative potential of voice AI for early detection, health monitoring, and reducing healthcare disparities. It also underscored the importance of dynamic governance to address the ethical and regulatory challenges of deploying AI in clinical settings.
KW - Bridge2AI
KW - Bridge2AI-Voice
KW - artificial intelligence
KW - audiomics
KW - voice biomarkers
UR - http://www.scopus.com/inward/record.url?scp=85212676211&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85212676211&partnerID=8YFLogxK
U2 - 10.3389/fdgth.2024.1484503
DO - 10.3389/fdgth.2024.1484503
M3 - Short survey
AN - SCOPUS:85212676211
SN - 2673-253X
VL - 6
JO - Frontiers in Digital Health
JF - Frontiers in Digital Health
M1 - 1484503
ER -